Goodwill and Intangible Assets

12 Months Ended

Dec. 31, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The changes in the carrying amount of goodwill are as follows:



	Automation and Analytics			Medication Adherence			Total
	(In thousands)
Net balance as of December 31, 2015	$	54,316		$	93,590		$	147,906
Additions ⁽¹⁾	163,599			20,832			184,431
Adjustments ⁽²⁾	(2,833		)	(1,780		)	(4,613		)
Net balance as of December 31, 2016	215,082			112,642			327,724
Additions ⁽³⁾	3,113			3,400			6,513
Adjustments ⁽²⁾	2,656			858			3,514
Net balance as of December 31, 2017	$	220,851		$	116,900		$	337,751

_________________________________________________

(1) Additions to goodwill as a result of the Aesynt acquisition in January 2016 and Ateb acquisition in December 2016.

(2)Adjustments reflect foreign currency exchange rate fluctuations.

(3) Additions to goodwill in Automation and Analytics segment was a result of the InPharmics acquisition in April 2017. Additions to goodwill in Medication Adherence segment represent adjustments to the preliminary value assigned to goodwill in connection with Ateb acquisition to reflect measurement period adjustments related to accounts receivable, other non-current assets and other liabilities of $0.1 million, $0.7 million and $2.6 million, respectively.

Intangible assets, net

The carrying amounts of intangible assets and useful lives as of December 31, 2017 were as follows:



	December 31, 2017
	Gross carrying amount		Accumulated amortization			Foreign currency exchange rate fluctuations		Net carrying amount		Useful life (years)
	(In thousands, except for years)
Customer relationships	$	133,913	$	(33,526	)	$	65	$	100,452	1 - 30
Acquired technology	74,593		(21,523		)	34		53,104		3 - 20
Backlog	21,712		(17,544		)	—		4,168		1 - 4
Trade names	8,716		(4,719		)	6		4,003		1 - 12
Patents	3,296		(1,418		)	2		1,880		2 - 20
Non-compete agreements	1,900		(1,300		)	—		600		3
In process technology	3,900		—			—		3,900		-
Total intangibles assets, net	$	248,030	$	(80,030	)	$	107	$	168,107

The carrying amounts of intangible assets and useful lives as of December 31, 2016 were as follows:



	December 31, 2016
	Gross carrying amount		Accumulated amortization			Foreign currency exchange rate fluctuations			Net carrying amount		Useful life (years)
	(In thousands, except for years)
Customer relationships	$	133,358	$	(20,930	)	$	(596	)	$	111,832	1 - 30
Acquired technology	73,599		(13,287		)	(159		)	60,153		3 - 20
Backlog	20,550		(14,083		)	—			6,467		1 - 3
Trade names	8,667		(3,887		)	(31		)	4,749		1 - 12
Patents	3,154		(1,264		)	—			1,890		2 - 20
Non-compete agreements	1,900		(608		)	—			1,292		3
In-process technology	3,900		—			—			3,900		-
Total intangibles assets, net	$	245,128	$	(54,059	)	$	(786	)	$	190,283

Amortization expense of intangible assets was $25.6 million, $36.1 million and $6.9 million for the years ended December 31, 2017, December 31, 2016 and December 31, 2015, respectively.

The estimated future amortization expenses for intangible assets are as follows:



For the year ended December 31,	(In thousands)
2018	$	23,433
2019	17,953
2020	16,739
2021	15,439
2022	13,973
Thereafter (excluding in-process technology)	76,670
Total	$	164,207

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details